Search Results


Mon, Nov 9, 2009 9:00am		7th Annual Vaccines: All Things Considered - Conference (Washington D.C)
Mon, Dec 7, 2009		Vaccine Technology 2009 Conference - Conference (BSG House, London, UK) With more targets, more investment and more oppportunity than ever, vaccine technology is among the most dynamic in biomedicine today. Advances in reverse vaccinology, computer-aided biotechnology and disposable technologies are revolutionising R&D for infectious disease, paediatric and cancer therapies. Allied with new developments in formualtion, informatics and process development, the market will see growth of over 300% between 2009 and 2023.
Tue, Dec 8, 2009		Vaccine Technology 2009 Conference - Conference (BSG House, London, UK) With more targets, more investment and more oppportunity than ever, vaccine technology is among the most dynamic in biomedicine today. Advances in reverse vaccinology, computer-aided biotechnology and disposable technologies are revolutionising R&D for infectious disease, paediatric and cancer therapies. Allied with new developments in formualtion, informatics and process development, the market will see growth of over 300% between 2009 and 2023.
Fri, Feb 26, 2010		The Bacteriophage in Biology, Biotechnology and Medicine - Conference (The BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AX, UK.) After our successful Bacteriophage Applications - current and potential applications in biotechnology, agriculture and medicine event which took place 16th May 2006 and Bacteriophages: Nature and Exploitation event which took place in 22 February 2008 we are delighted to announce our follow up event. "Bacteriophages are the most abundant biological entities on earth and are major drivers of bacterial adaptive evolution. Studies on phage biology underpin our core knowledge of modern molecular biology - and phage research has provided many of the techniques and biochemical reagents used by all molecular biologists. This meeting is the third in a successful biennial series discussing the biological nature of bacteriophages, and their exploitation in basic microbiology (for genetics and functional genomics); diagnostics, ecology and evolution, phage display, vaccines, and in therapeutics in animal and human infections. The general structure of the meeting is to have short, expert presentations on this spectrum of topics, plus short Q&A sessions and offered posters. The meeting will be of interest to anyone who is currently using phages in their research work or who might be interested in the potential application of phages for basic biology, and applied topics such as bacterial diagnostics, vaccine development and phage therapy". Meeting chair - Professor George Salmond, University of Cambridge, UK
Fri, Mar 12, 2010		Recombinant vaccines - right molecule, right place, right time? - Conference (The BioPark, Hertfordshire, UK) "Huge technological advances have been made recently in the genomic and post-genomic analyses of pathogens and disease. To exploit these advances for the production of successful recombinant vaccines we need strategies to select appropriate molecules and to deliver them appropriately to stimulate protective immune responses. This meeting will explore both candidate discovery and the tools for delivering vaccines effectively". Meeting Chair: Dr Alasdair Nisbet, Moredun Research Institute, UK. The meeting has CPD approval.

powered by VTCalendar 2.2.1

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.